Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution
Studdert, D.M.; Mello, M.M.; Brennan, T.A.
New England Journal of Medicine 351(18): 1891-1900
2004
ISSN/ISBN: 0028-4793
PMID: 15509824
DOI: 10.1056/nejmlim042229
Accession: 049082715
PDF emailed within 0-6 h: $19.90
Related References
Schetky, D.H. 2008: Conflicts of interest between physicians and the pharmaceutical industry and special interest groups Child and Adolescent Psychiatric Clinics of North America 17(1): 113-25 Ix-XRubin, E.B.; Bernat, J.L. 2008: Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine Headache 48(10): 1545-1549
Salas, Sía.P.; Osorio F, M.; Vial C, P.; Rehbein V, A.María.; Salas A, C.; Beca I, J.Pablo. 2006: Conflicts of interest in clinical practice. Ethical analysis of some relationships with the pharmaceutical industry Revista Medica de Chile 134(12): 1576-1582
Johns, M.M.E.; Barnes, M.; Florencio, P.S. 2003: Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust JAMA 289(6): 741-746
Lu, Y; Sharara, N; Jones, D J.; Kaltenbach, T; Martel, M; Barkun, A N. 2015: Su1103 Introducing Non-Financial Conflicts of Interest (COI) and Refining Financial Conflicts of Interest in Consensus Guideline Development Gastroenterology 148(4): S-408-S-409
Doherty, R.B. 1988: Physicians and financial conflicts of interest: the next battleground Internist 29(9): 23-5 38
Haines, I.E.; Olver, I.N. 2008: Are self-regulation and declaration of conflict of interest still the benchmark for relationships between physicians and industry? Medical Journal of Australia 189(5): 263-266
Shamasunder, B.; Bero, L. 2002: Financial ties and conflicts of interest between pharmaceutical and tobacco companies JAMA 288(6): 738-744
Niforatos, J.D.; Chaitoff, A.; Mercer, M.Beth.; Yu, P-Chun.; Rose, S.L. 2019: Association Between Public Trust and Provider Specialty Among Physicians With Financial Conflicts of Interest Mayo Clinic Proceedings 94(12): 2467-2475
Solyom, A.E. 2004: Ethical challenges to the integrity of physicians: financial conflicts of interest in clinical research Accountability in Research 11(2): 119-139
Klemperer, D. 2009: Self-help groups conflicts of interest through sponsoring by the pharmaceutical industry Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 52(1): 71-76
Booth, C.M.; Detsky, A.S. 2019: From the $80 hamburger to managing conflicts of interest with the pharmaceutical industry Bmj 365: L1939
Lee, K.C.; Chuang, S-Kiang. 2020: Financial conflicts of interest in dentistry: how much money do providers receive from industry? General Dentistry 68(1): 56-60
Nahata, M.C. 1994: More conflicts of interest: review articles sponsored by the pharmaceutical industry JAMA 272(16): 1253-1254
Cosgrove, L.; Wheeler, E. E. 2013: Industry's colonization of psychiatry: Ethical and practical implications of financial conflicts of interest in the DSM-5 Feminism and Psychology 23(1): 93-106
Tringale, K.R.; Hattangadi-Gluth, J.A. 2017: Are We for Sale? Awareness of Industry-Related Financial Conflicts of Interest in Radiation Oncology International Journal of Radiation Oncology Biology Physics 99(2): 255-258
DeAngelis, C.D.; Fontanarosa, P.B.; Flanagin, A. 2001: Reporting financial conflicts of interest and relationships between investigators and research sponsors JAMA 286(1): 89-91
Ehrlich, O.; Wingate, L.; Heller, C.; de Melo-Martin, I. 2019: When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest Bmc Medical Ethics 20(1): 96
Braunstein, J.B.; Schulman, S.P.; Powe, N.R. 2003: Impact of investigator financial conflicts of interest and industry sponsorship of clinical trials on patient participation Circulation 108(17): IV758
Tereskerz, P.M.; Moreno, J. 2005: Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research Accountability in Research 12(2): 139-155